Contemporary update of cancer control after radical prostatectomy in the UK

British Journal of Cancer

Volumn 91, Issue 11, 2004, Pages 1853-1857

  Winkler, M H ^a,f   Khan, F A ^a   Shabir, M ^a   Okeke, A ^b   Sugiono, M ^b   McInerney, P ^c   Boustead, G B ^d   Persad, R ^e   Kaisary, A V ^a   Gillatt, D A ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c DERRIFORD HOSPITAL   (United Kingdom)

^d LISTER HOSPITAL   (United Kingdom)

^e BRISTOL ROYAL INFIRMARY   (United Kingdom)

^f NONE   (United Kingdom)

Author keywords

Adenocarcinoma; Prostate neoplasm; Prostate specific antigen; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER CONTROL; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE SURGERY; PROSTATECTOMY; TREATMENT OUTCOME; UNITED KINGDOM;

GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 19944427032     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602206     Document Type: Article

References (17)

1. Bott SR, Kirby RS (2002) Avoidance and management of positive surgical margins before, during and after radical prostatectomy. Prostate Cancer Prostatic Dis 5(4): 252-263
2. D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP (2002) Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 95(2): 281-286
3. Doherty AP, Bower M, Smith GL, Miano R, Mannion EM, Mitchell H, Christmas TJ (2000) Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer 83(11): 1432-1436
4. Feneley MR, Gillatt DA, Hehir M, Kirby RS (1996) A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome. Br J Urol 78(6): 911-918, (discussion 919-920)
5. Freedland SJ, Presti Jr JC, Amling CL, Kane CJ, Aronson WJ, Dorey F, Terris MK, SEARCH Database Study Group (2003) Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology 61(4): 736-741
6. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28(3): 555-565
7. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169(2): 517-523
8. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, Andersson SO, Spangberg A, Busch C, Nordling S, Palmgren J, Adami HO, Johansson JE, Norlen BJ, Scandinavian Prostatic Cancer Group Study Number (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347(11): 781-789
9. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS (2003) Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 21(3): 401-405
10. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT (2002) Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167(2 Part 1): 528-534
11. Litwiller SE, Djavan B, Klopukh BV, Richier JC, Roehrborn CG (1995) Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological Disorders. Urology 45(5): 813-822
12. Melia J, Moss S. (2001) Survey of the rate of PSA testing in general practice. Br J Cancer 85(5): 656-657
13. Moul JW, Wu H, Sun L, McLeod DG, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D, Rich NM (2002) Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database. Surgery 132(2): 213-219
14. Oliver SE, Donovan JL, Peters TJ, Frankel S, Hamdy FC, Neal DE (2003) Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion. BJU Int 91(4): 331-336, (discussion 336)
15. Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sozen S, Gill H (1998) Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 160: 2412-2417
16. Ung JO, Richie JP, Chen MH, Renshaw AA, D'Amico AV (2002) Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 60(3): 458-463
17. Walsh PC. (2000) Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 163(6): 1802-1807